Clinical trial
Neurostimulation for the Treatment of Post-Stroke Aphasia
NCT05194566 is registered in ClinicalTrials.gov with QVITI S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurostimulation for the Treatment of Post-Stroke Aphasia
- Lead sponsor
- QVITI S.A.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 6, 2023
- Completion date
- December 31, 2026
- Enrollment
- 64 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
post-stroke aphasia